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If we accept the idea that we are not able 
to “predict” the future of influenza, then 
we need to understand how we can pre-
pare for the emergence of a new pandemic. 
Furthermore, if we cannot predict when 
our next problem is going to happen, we 
need to be able to recognize the problem 
as soon as it happens. This is why optimal 
influenza surveillance should be our first 
line of response. Another item of impor-
tance that is unpredictable is the virulence 
of a new, emergent strain of influenza. If 
the new strain is of low virulence, most 
patients will have a mild disease and some 
of them may even be asymptomatic. Most of 
the patients with this new virus will remain 
in the community setting (Figure 1, A1). 
Under the circumstances of a new pan-
demic with a low virulence virus, surveil-
lance can be focused on visits to doctors’ 
offices, drug stores, or illness reports from 
work or school. Local health departments 
typically perform these types of surveillance 
mechanisms. With the progression of the 
epidemic, and when abnormal hosts are 
infected, some patients will develop more 
serious disease requiring hospitalization 
(Figure 1, B1). On the other hand, if the 
novel virus is highly virulent, the initial 
cases will likely be complicated with pneu-
monia, and patients will require admission 
to the hospital, intensive care treatment, 
and mechanical ventilation (Figure 1, A2). 
In this type of scenario, the recognition of 
initial cases must occur in the hospital set-
ting. As the pandemic progresses, patients 
with less severe disease will be recognized 
in the community (Figure 1, B2). A local 
outbreak of previously healthy patients with 
severe pneumonia requiring intensive care 
admission will be the first manifestations of 
a pandemic due to a highly virulent virus. 
Surveillance of severe pneumonia through 
a hospital infection prevention and control 
program will be our best approach for early 
identification of highly virulent virus.
Early recognition of a new pandemic 
should trigger a series of research stud-
ies. Investigators will need to characterize 
the new virus, define mechanisms of viral 
transmission, define clinical presentation, 
characterize patients at high risk for poor 
outcomes, and develop and test preven-
tion and treatment strategies. To generate 
these types of knowledge in a short period 
of time requires a change in our stand-
ard approach of performing research. A 
traditional research model consists of 
investigators working in isolation in his 
or her laboratory. This must change to a 
new research model with basic and clinical 
investigators working in open collabora-
tion. This new research model is defined 
by the United States National Institutes 
of Health as Clinical and Translational 
Science. Collaboration of many experts 
in the field of influenza is happening in 
some Universities from around the globe. 
Well-funded, multidisciplinary collabora-
tion is essential to face the challenges of 
influenza.
We may not be able to predict the influ-
enza virus, but we can definitely study the 
virus and generate the necessary knowledge 
for its prevention and control.
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Figure 1 | Disease severity modeling and optimal surveillance approaches for emerging influenza 
viruses according to viral virulence.
